PMC:7247521 / 25290-28994
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 361 | 1369-1373 | Gene | denotes | OCT2 | Gene:6582 |
| 362 | 1175-1180 | Species | denotes | Human | Tax:9606 |
| 363 | 1260-1265 | Species | denotes | Human | Tax:9606 |
| 364 | 1462-1467 | Species | denotes | Human | Tax:9606 |
| 365 | 1518-1521 | Species | denotes | Rat | Tax:10116 |
| 366 | 1120-1125 | Chemical | denotes | Caco2 | |
| 367 | 1348-1350 | Chemical | denotes | TC | MESH:D013667 |
| 368 | 1432-1436 | Chemical | denotes | MTDD | |
| 369 | 1006-1014 | Disease | denotes | toxicity | MESH:D064420 |
| 370 | 1422-1430 | Disease | denotes | toxicity | MESH:D064420 |
| 371 | 1528-1536 | Disease | denotes | Toxicity | MESH:D064420 |
| 372 | 1549-1563 | Disease | denotes | Hepatotoxicity | MESH:D056486 |
| 373 | 1569-1587 | Disease | denotes | Skin Sensitisation | MESH:D012871 |
| 374 | 1600-1608 | Disease | denotes | toxicity | MESH:D064420 |
| 375 | 1127-1133 | CellLine | denotes | Caco-2 | CVCL:0025 |
| 383 | 1921-1929 | Gene | denotes | Helicase | Gene:164045 |
| 384 | 1988-1993 | Gene | denotes | PLpro | Gene:43740578 |
| 385 | 2005-2009 | Gene | denotes | Mpro | Gene:8673700 |
| 386 | 2021-2025 | Gene | denotes | Mpro | Gene:8673700 |
| 387 | 1958-1966 | Gene | denotes | Helicase | Gene:164045 |
| 388 | 1850-1858 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 389 | 2048-2051 | Disease | denotes | XCH | |
| 391 | 3689-3692 | Disease | denotes | XCH | |
| 403 | 2727-2731 | Gene | denotes | OCT2 | Gene:6582 |
| 404 | 2854-2858 | Gene | denotes | hERG | Gene:2078 |
| 405 | 2872-2876 | Gene | denotes | hERG | Gene:2078 |
| 406 | 2896-2899 | Species | denotes | rat | Tax:10116 |
| 407 | 2787-2795 | Disease | denotes | toxicity | MESH:D064420 |
| 408 | 2820-2828 | Disease | denotes | toxicity | MESH:D064420 |
| 409 | 2906-2914 | Disease | denotes | toxicity | MESH:D064420 |
| 410 | 2923-2937 | Disease | denotes | hepatotoxicity | MESH:D056486 |
| 411 | 2939-2957 | Disease | denotes | skin sensitisation | MESH:D012871 |
| 412 | 2970-2978 | Disease | denotes | toxicity | MESH:D064420 |
| 413 | 2191-2197 | CellLine | denotes | Caco-2 | CVCL:0025 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T283 | 36-45 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T284 | 94-98 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T285 | 153-162 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T286 | 438-447 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T287 | 590-594 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T288 | 641-650 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T289 | 714-730 | UBERON:0005409 | denotes | gastrointestinal |
| T290 | 1055-1064 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T291 | 1120-1125 | CL_1 | denotes | Caco2 |
| T292 | 1127-1133 | CL_1 | denotes | Caco-2 |
| T293 | 1152-1162 | UBERON:0000160 | denotes | Intestinal |
| T294 | 1175-1180 | SP_6;NCBITaxon:9606 | denotes | Human |
| T295 | 1260-1265 | SP_6;NCBITaxon:9606 | denotes | Human |
| T296 | 1273-1284 | UBERON:0000120 | denotes | Blood Brain |
| T297 | 1307-1310 | UBERON:0001017 | denotes | CNS |
| T298 | 1312-1334 | UBERON:0001017 | denotes | Central Nervous System |
| T299 | 1369-1373 | PR:000013036 | denotes | OCT2 |
| T300 | 1375-1380 | UBERON:0002113 | denotes | Renal |
| T301 | 1381-1395 | CHEBI:25697;CHEBI:25697;PR:000014988 | denotes | Organic Cation |
| T302 | 1396-1409 | PR:000014988 | denotes | Transporter 2 |
| T303 | 1462-1467 | SP_6;NCBITaxon:9606 | denotes | Human |
| T304 | 1470-1474 | PR:P11308 | denotes | hERG |
| T305 | 1481-1485 | PR:P11308 | denotes | hERG |
| T306 | 1513-1517 | UBERON:0000165 | denotes | Oral |
| T307 | 1518-1521 | NCBITaxon:10114 | denotes | Rat |
| T308 | 1589-1591 | UBERON:0001448 | denotes | MT |
| T309 | 1818-1827 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T310 | 1850-1858 | SP_7 | denotes | COVID-19 |
| T311 | 1879-1888 | PG_2 | denotes | E protein |
| T312 | 1890-1893 | CHEBI:24870;CHEBI:24870 | denotes | ion |
| T313 | 1914-1919 | PR:000000125 | denotes | nsp13 |
| T314 | 1951-1956 | PR:000000125 | denotes | nsp13 |
| T315 | 2014-2016 | CHEBI:15379;CHEBI:15379 | denotes | O2 |
| T342 | 2108-2117 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T343 | 2151-2155 | UBERON:0000165 | denotes | oral |
| T344 | 2191-2197 | CL_1 | denotes | Caco-2 |
| T345 | 2248-2252 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T346 | 2298-2307 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T347 | 2323-2329 | UBERON:0000479 | denotes | tissue |
| T348 | 2343-2349 | UBERON:0000479 | denotes | tissue |
| T349 | 2364-2370 | UBERON:0001969 | denotes | plasma |
| T350 | 2452-2467 | CHEBI:52217;CHEBI:52217 | denotes | pharmacological |
| T351 | 2539-2558 | UBERON:0000120 | denotes | blood-brain barrier |
| T352 | 2560-2563 | UBERON:0000120 | denotes | BBB |
| T353 | 2569-2591 | UBERON:0001017 | denotes | central nervous system |
| T354 | 2593-2596 | UBERON:0001017 | denotes | CNS |
| T355 | 2615-2624 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T356 | 2642-2647 | UBERON:0002113 | denotes | renal |
| T357 | 2691-2696 | UBERON:0002113 | denotes | renal |
| T358 | 2697-2711 | CHEBI:25697;CHEBI:25697;PR:000014988 | denotes | organic cation |
| T359 | 2712-2725 | PR:000014988 | denotes | transporter 2 |
| T360 | 2727-2731 | PR:000013036 | denotes | OCT2 |
| T361 | 2746-2755 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T362 | 2815-2819 | CHEBI:34018;CHEBI:34018 | denotes | AMES |
| T363 | 2854-2858 | PR:P11308 | denotes | hERG |
| T364 | 2861-2870 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
| T365 | 2872-2876 | PR:P11308 | denotes | hERG |
| T366 | 2880-2889 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
| T367 | 2891-2895 | UBERON:0000165 | denotes | oral |
| T368 | 2896-2899 | NCBITaxon:10114 | denotes | rat |
| T372 | 3018-3027 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T74 | 1152-1162 | Body_part | denotes | Intestinal | http://purl.org/sig/ont/fma/fma7199 |
| T75 | 1183-1187 | Body_part | denotes | Skin | http://purl.org/sig/ont/fma/fma7163 |
| T76 | 1189-1193 | Body_part | denotes | Skin | http://purl.org/sig/ont/fma/fma7163 |
| T77 | 1273-1278 | Body_part | denotes | Blood | http://purl.org/sig/ont/fma/fma9670 |
| T78 | 1279-1284 | Body_part | denotes | Brain | http://purl.org/sig/ont/fma/fma50801 |
| T79 | 1307-1310 | Body_part | denotes | CNS | http://purl.org/sig/ont/fma/fma55675 |
| T80 | 1312-1334 | Body_part | denotes | Central Nervous System | http://purl.org/sig/ont/fma/fma55675 |
| T81 | 1320-1334 | Body_part | denotes | Nervous System | http://purl.org/sig/ont/fma/fma7157 |
| T82 | 1569-1573 | Body_part | denotes | Skin | http://purl.org/sig/ont/fma/fma7163 |
| T83 | 1859-1867 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T84 | 1881-1888 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T85 | 2198-2202 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T86 | 2225-2229 | Body_part | denotes | skin | http://purl.org/sig/ont/fma/fma7163 |
| T87 | 2323-2329 | Body_part | denotes | tissue | http://purl.org/sig/ont/fma/fma9637 |
| T88 | 2343-2349 | Body_part | denotes | tissue | http://purl.org/sig/ont/fma/fma9637 |
| T89 | 2364-2370 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T90 | 2539-2544 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
| T91 | 2545-2550 | Body_part | denotes | brain | http://purl.org/sig/ont/fma/fma50801 |
| T92 | 2569-2591 | Body_part | denotes | central nervous system | http://purl.org/sig/ont/fma/fma55675 |
| T93 | 2593-2596 | Body_part | denotes | CNS | http://purl.org/sig/ont/fma/fma55675 |
| T94 | 2939-2943 | Body_part | denotes | skin | http://purl.org/sig/ont/fma/fma7163 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T18 | 1183-1187 | Body_part | denotes | Skin | http://purl.obolibrary.org/obo/UBERON_0000014 |
| T19 | 1189-1193 | Body_part | denotes | Skin | http://purl.obolibrary.org/obo/UBERON_0000014 |
| T20 | 1273-1292 | Body_part | denotes | Blood Brain Barrier | http://purl.obolibrary.org/obo/UBERON_0000120 |
| T21 | 1307-1310 | Body_part | denotes | CNS | http://purl.obolibrary.org/obo/UBERON_0001017 |
| T22 | 1312-1334 | Body_part | denotes | Central Nervous System | http://purl.obolibrary.org/obo/UBERON_0001017 |
| T23 | 1569-1573 | Body_part | denotes | Skin | http://purl.obolibrary.org/obo/UBERON_0000014 |
| T24 | 2225-2229 | Body_part | denotes | skin | http://purl.obolibrary.org/obo/UBERON_0000014 |
| T25 | 2323-2329 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
| T26 | 2343-2349 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
| T27 | 2539-2558 | Body_part | denotes | blood-brain barrier | http://purl.obolibrary.org/obo/UBERON_0000120 |
| T28 | 2539-2544 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
| T29 | 2545-2550 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/UBERON_0000955 |
| T30 | 2569-2591 | Body_part | denotes | central nervous system | http://purl.obolibrary.org/obo/UBERON_0001017 |
| T31 | 2577-2591 | Body_part | denotes | nervous system | http://purl.obolibrary.org/obo/UBERON_0001016 |
| T32 | 2593-2596 | Body_part | denotes | CNS | http://purl.obolibrary.org/obo/UBERON_0001017 |
| T33 | 2939-2943 | Body_part | denotes | skin | http://purl.obolibrary.org/obo/UBERON_0000014 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T59 | 1850-1858 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T166 | 613-614 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T167 | 816-817 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T168 | 837-838 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
| T169 | 1120-1125 | http://purl.obolibrary.org/obo/CLO_0002172 | denotes | Caco2 |
| T170 | 1120-1125 | http://purl.obolibrary.org/obo/CLO_0051943 | denotes | Caco2 |
| T171 | 1120-1125 | http://purl.obolibrary.org/obo/CLO_0051958 | denotes | Caco2 |
| T172 | 1120-1125 | http://purl.obolibrary.org/obo/CLO_0051960 | denotes | Caco2 |
| T173 | 1127-1133 | http://purl.obolibrary.org/obo/CLO_0002172 | denotes | Caco-2 |
| T174 | 1127-1133 | http://purl.obolibrary.org/obo/CLO_0051943 | denotes | Caco-2 |
| T175 | 1127-1133 | http://purl.obolibrary.org/obo/CLO_0051958 | denotes | Caco-2 |
| T176 | 1127-1133 | http://purl.obolibrary.org/obo/CLO_0051960 | denotes | Caco-2 |
| T177 | 1152-1162 | http://purl.obolibrary.org/obo/UBERON_0000160 | denotes | Intestinal |
| T178 | 1152-1162 | http://www.ebi.ac.uk/efo/EFO_0000834 | denotes | Intestinal |
| T179 | 1175-1180 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | Human |
| T180 | 1183-1187 | http://purl.obolibrary.org/obo/UBERON_0000014 | denotes | Skin |
| T181 | 1183-1187 | http://purl.obolibrary.org/obo/UBERON_0001003 | denotes | Skin |
| T182 | 1183-1187 | http://purl.obolibrary.org/obo/UBERON_0002097 | denotes | Skin |
| T183 | 1183-1187 | http://purl.obolibrary.org/obo/UBERON_0002199 | denotes | Skin |
| T184 | 1183-1187 | http://www.ebi.ac.uk/efo/EFO_0000962 | denotes | Skin |
| T185 | 1189-1193 | http://purl.obolibrary.org/obo/UBERON_0000014 | denotes | Skin |
| T186 | 1189-1193 | http://purl.obolibrary.org/obo/UBERON_0001003 | denotes | Skin |
| T187 | 1189-1193 | http://purl.obolibrary.org/obo/UBERON_0002097 | denotes | Skin |
| T188 | 1189-1193 | http://purl.obolibrary.org/obo/UBERON_0002199 | denotes | Skin |
| T189 | 1189-1193 | http://www.ebi.ac.uk/efo/EFO_0000962 | denotes | Skin |
| T190 | 1260-1265 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | Human |
| T191 | 1273-1278 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | Blood |
| T192 | 1273-1278 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | Blood |
| T193 | 1279-1284 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | Brain |
| T194 | 1279-1284 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | Brain |
| T195 | 1307-1310 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | CNS |
| T196 | 1307-1310 | http://www.ebi.ac.uk/efo/EFO_0000908 | denotes | CNS |
| T197 | 1307-1310 | http://purl.obolibrary.org/obo/UBERON_0001017 | denotes | CNS |
| T198 | 1312-1334 | http://purl.obolibrary.org/obo/UBERON_0001017 | denotes | Central Nervous System |
| T199 | 1312-1334 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | Central Nervous System |
| T200 | 1312-1334 | http://www.ebi.ac.uk/efo/EFO_0000908 | denotes | Central Nervous System |
| T201 | 1381-1388 | http://purl.obolibrary.org/obo/OBI_0100026 | denotes | Organic |
| T202 | 1381-1388 | http://purl.obolibrary.org/obo/UBERON_0000468 | denotes | Organic |
| T203 | 1462-1467 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | Human |
| T204 | 1545-1547 | http://purl.obolibrary.org/obo/CLO_0004265 | denotes | HT |
| T205 | 1569-1573 | http://purl.obolibrary.org/obo/UBERON_0000014 | denotes | Skin |
| T206 | 1569-1573 | http://purl.obolibrary.org/obo/UBERON_0001003 | denotes | Skin |
| T207 | 1569-1573 | http://purl.obolibrary.org/obo/UBERON_0002097 | denotes | Skin |
| T208 | 1569-1573 | http://purl.obolibrary.org/obo/UBERON_0002199 | denotes | Skin |
| T209 | 1569-1573 | http://www.ebi.ac.uk/efo/EFO_0000962 | denotes | Skin |
| T210 | 1869-1870 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T211 | 1904-1905 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
| T212 | 1944-1946 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
| T213 | 1978-1983 | http://purl.obolibrary.org/obo/CLO_0002821 | denotes | D: S1 |
| T214 | 1978-1983 | http://purl.obolibrary.org/obo/CLO_0002822 | denotes | D: S1 |
| T215 | 2139-2140 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T216 | 2191-2202 | http://purl.obolibrary.org/obo/CLO_0002172 | denotes | Caco-2 cell |
| T217 | 2225-2229 | http://purl.obolibrary.org/obo/UBERON_0000014 | denotes | skin |
| T218 | 2225-2229 | http://purl.obolibrary.org/obo/UBERON_0001003 | denotes | skin |
| T219 | 2225-2229 | http://purl.obolibrary.org/obo/UBERON_0002097 | denotes | skin |
| T220 | 2225-2229 | http://purl.obolibrary.org/obo/UBERON_0002199 | denotes | skin |
| T221 | 2225-2229 | http://www.ebi.ac.uk/efo/EFO_0000962 | denotes | skin |
| T222 | 2364-2370 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T223 | 2539-2544 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| T224 | 2539-2544 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
| T225 | 2545-2550 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| T226 | 2545-2550 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | brain |
| T227 | 2569-2591 | http://purl.obolibrary.org/obo/UBERON_0001017 | denotes | central nervous system |
| T228 | 2569-2591 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | central nervous system |
| T229 | 2569-2591 | http://www.ebi.ac.uk/efo/EFO_0000908 | denotes | central nervous system |
| T230 | 2593-2596 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | CNS |
| T231 | 2593-2596 | http://www.ebi.ac.uk/efo/EFO_0000908 | denotes | CNS |
| T232 | 2593-2596 | http://purl.obolibrary.org/obo/UBERON_0001017 | denotes | CNS |
| T233 | 2635-2636 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T234 | 2697-2704 | http://purl.obolibrary.org/obo/OBI_0100026 | denotes | organic |
| T235 | 2697-2704 | http://purl.obolibrary.org/obo/UBERON_0000468 | denotes | organic |
| T236 | 2939-2943 | http://purl.obolibrary.org/obo/UBERON_0000014 | denotes | skin |
| T237 | 2939-2943 | http://purl.obolibrary.org/obo/UBERON_0001003 | denotes | skin |
| T238 | 2939-2943 | http://purl.obolibrary.org/obo/UBERON_0002097 | denotes | skin |
| T239 | 2939-2943 | http://purl.obolibrary.org/obo/UBERON_0002199 | denotes | skin |
| T240 | 2939-2943 | http://www.ebi.ac.uk/efo/EFO_0000962 | denotes | skin |
| T241 | 3011-3017 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
| T242 | 3143-3145 | http://purl.obolibrary.org/obo/CLO_0008933 | denotes | S5 |
| T243 | 3324-3326 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
| T244 | 3434-3437 | http://purl.obolibrary.org/obo/CLO_0007875 | denotes | MS1 |
| T245 | 3434-3437 | http://purl.obolibrary.org/obo/CLO_0052410 | denotes | MS1 |
| T246 | 3466-3468 | http://purl.obolibrary.org/obo/CLO_0009126 | denotes | SR |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T147 | 94-98 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T148 | 250-252 | Chemical | denotes | MW | http://purl.obolibrary.org/obo/CHEBI_74709 |
| T149 | 501-503 | Chemical | denotes | MW | http://purl.obolibrary.org/obo/CHEBI_74709 |
| T150 | 590-594 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T151 | 706-708 | Chemical | denotes | S3 | http://purl.obolibrary.org/obo/CHEBI_29388 |
| T152 | 1389-1395 | Chemical | denotes | Cation | http://purl.obolibrary.org/obo/CHEBI_36916 |
| T153 | 1477-1479 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
| T154 | 1492-1494 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
| T155 | 1565-1567 | Chemical | denotes | SS | http://purl.obolibrary.org/obo/CHEBI_73653 |
| T156 | 1589-1591 | Chemical | denotes | MT | http://purl.obolibrary.org/obo/CHEBI_73614 |
| T157 | 1859-1867 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T158 | 1872-1874 | Chemical | denotes | M3 | http://purl.obolibrary.org/obo/CHEBI_51083|http://purl.obolibrary.org/obo/CHEBI_53453 |
| T160 | 1881-1888 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T161 | 1890-1893 | Chemical | denotes | ion | http://purl.obolibrary.org/obo/CHEBI_24870 |
| T162 | 1907-1909 | Chemical | denotes | M3 | http://purl.obolibrary.org/obo/CHEBI_51083|http://purl.obolibrary.org/obo/CHEBI_53453 |
| T164 | 1967-1970 | Chemical | denotes | ADP | http://purl.obolibrary.org/obo/CHEBI_16761|http://purl.obolibrary.org/obo/CHEBI_456216|http://purl.obolibrary.org/obo/CHEBI_73342 |
| T167 | 2014-2016 | Chemical | denotes | O2 | http://purl.obolibrary.org/obo/CHEBI_15379 |
| T168 | 2248-2252 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T169 | 2697-2711 | Chemical | denotes | organic cation | http://purl.obolibrary.org/obo/CHEBI_25697 |
| T170 | 2705-2711 | Chemical | denotes | cation | http://purl.obolibrary.org/obo/CHEBI_36916 |
| T171 | 2861-2870 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T172 | 2877-2879 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
| T173 | 2880-2889 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T174 | 3116-3118 | Chemical | denotes | M3 | http://purl.obolibrary.org/obo/CHEBI_51083|http://purl.obolibrary.org/obo/CHEBI_53453 |
| T176 | 3143-3145 | Chemical | denotes | S5 | http://purl.obolibrary.org/obo/CHEBI_29386 |
| T177 | 3179-3189 | Chemical | denotes | Medicarpin | http://purl.obolibrary.org/obo/CHEBI_6714 |
| T178 | 3201-3211 | Chemical | denotes | Cianidanol | http://purl.obolibrary.org/obo/CHEBI_15600 |
| T179 | 3271-3273 | Chemical | denotes | O2 | http://purl.obolibrary.org/obo/CHEBI_15379 |
| T180 | 3327-3336 | Chemical | denotes | letrozole | http://purl.obolibrary.org/obo/CHEBI_6413 |
| T181 | 3413-3423 | Chemical | denotes | naringenin | http://purl.obolibrary.org/obo/CHEBI_50202 |
| T182 | 3438-3451 | Chemical | denotes | Leucocyanidol | http://purl.obolibrary.org/obo/CHEBI_11412|http://purl.obolibrary.org/obo/CHEBI_15758 |
| T184 | 3536-3539 | Chemical | denotes | Tyr | http://purl.obolibrary.org/obo/CHEBI_17895|http://purl.obolibrary.org/obo/CHEBI_18186|http://purl.obolibrary.org/obo/CHEBI_46858 |
| T187 | 3542-3545 | Chemical | denotes | Phe | http://purl.obolibrary.org/obo/CHEBI_17295|http://purl.obolibrary.org/obo/CHEBI_29997 |
| T189 | 3562-3576 | Chemical | denotes | Liquiritigenin | http://purl.obolibrary.org/obo/CHEBI_28777 |
| T190 | 3595-3604 | Chemical | denotes | taxifolin | http://purl.obolibrary.org/obo/CHEBI_38747 |
| T191 | 3657-3666 | Chemical | denotes | flavanone | http://purl.obolibrary.org/obo/CHEBI_5070 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T96 | 1152-1173 | http://purl.obolibrary.org/obo/GO_0050892 | denotes | Intestinal Absorption |
| T97 | 1381-1407 | http://purl.obolibrary.org/obo/GO_0015695 | denotes | Organic Cation Transporter |
| T98 | 1890-1901 | http://purl.obolibrary.org/obo/GO_0022831 | denotes | ion channel |
| T99 | 2697-2723 | http://purl.obolibrary.org/obo/GO_0015695 | denotes | organic cation transporter |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T170 | 0-45 | Sentence | denotes | 3.5 ADMET evaluation of the 67 key compounds |
| T171 | 46-201 | Sentence | denotes | Since in silico ADMET prediction can help early drug design and evaluation, ADMET properties of the 67 key compounds were predicted by SwissADME and pkCSM. |
| T172 | 202-396 | Sentence | denotes | Chemical properties including molecular weight (MW), rotatable bonds count, H-bond acceptors and donors count, TPSA and leadlikeness violations were calculated by SwissADME and shown as Fig. 8A. |
| T173 | 397-616 | Sentence | denotes | It is worth mentioning that 21 (31.34 %) compounds passed the stringent lead-like criteria (250 g/mol ≤ MW ≤ 350 g/mol, XLOGP ≤ 3.5 and rotatable bonds ≤ 7), which are excellent candidates for drug discovery (Fig. 7 A). |
| T174 | 617-742 | Sentence | denotes | And these lead-likeness compounds were further predicted by pkCSM, with the exception of S3 (low gastrointestinal absorption) |
| T175 | 743-815 | Sentence | denotes | Fig. 7 Chemical properties statistics of hub components in the formulae. |
| T176 | 816-818 | Sentence | denotes | A: |
| T177 | 819-1119 | Sentence | denotes | Molecular weight, B: rotatable bond count, C: H-bond acceptors count, D: H-bond donors count, E: topological polar surface area (TPSA), F: leadlikeness violations, G: pharmacokinetic and toxicity evaluated parameters of 20 leadlikeness compounds by pkCSM; green = good, yellow = tolerable, red = bad. |
| T178 | 1120-1126 | Sentence | denotes | Caco2: |
| T179 | 1127-1151 | Sentence | denotes | Caco-2 Permeability,HIA: |
| T180 | 1152-1188 | Sentence | denotes | Intestinal Absorption (Human), Skin: |
| T181 | 1189-1241 | Sentence | denotes | Skin Permeability, VDss: volume of distribution, FU: |
| T182 | 1242-1272 | Sentence | denotes | Fraction Unbound (Human), BBB: |
| T183 | 1273-1311 | Sentence | denotes | Blood Brain Barrier permeability, CNS: |
| T184 | 1312-1351 | Sentence | denotes | Central Nervous System permeability,TC: |
| T185 | 1352-1374 | Sentence | denotes | Total Clearance, OCT2: |
| T186 | 1375-1437 | Sentence | denotes | Renal Organic Cation Transporter 2, AMES: AMES toxicity, MTDD: |
| T187 | 1438-1512 | Sentence | denotes | Maximum Tolerated Dose (Human), hERG I/II: hERG I and II Inhibitors, LD50: |
| T188 | 1513-1548 | Sentence | denotes | Oral Rat Acute Toxicity (LD50), HT: |
| T189 | 1549-1568 | Sentence | denotes | Hepatotoxicity, SS: |
| T190 | 1569-1592 | Sentence | denotes | Skin Sensitisation, MT: |
| T191 | 1593-1740 | Sentence | denotes | Minnow toxicity. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) |
| T192 | 1741-1868 | Sentence | denotes | Fig. 8 Schematic (3D and 2D) representation that molecular model of specific compounds of each formulae with COVID-19 proteins. |
| T193 | 1869-2026 | Sentence | denotes | A: M3 and E protein [ion channel], B: M3 and nsp13 [Helicase NCB site], C: S1 and nsp13 [Helicase ADP site], D: S1 and PLpro, E: X2 and Mpro, F: O2 and Mpro. |
| T194 | 2027-2055 | Sentence | denotes | M: MXSG, S: SGMH, X: XCH, O: |
| T195 | 2056-2063 | Sentence | denotes | Others. |
| T196 | 2064-2243 | Sentence | denotes | Regarding the absorption parameters, all 20 compounds (Table 2 ) presented a promising oral availability including the optimal Caco-2 cell permeability, HIA and skin permeability. |
| T197 | 2244-2475 | Sentence | denotes | The drug distribution results showed that most of the compounds distributed in tissue (VDss> 0.45: tissue, VDss <−0.15: plasma) with good unbound fraction scores, thus becoming available to interact with the pharmacological target. |
| T198 | 2476-2598 | Sentence | denotes | Only compound W5 and W11 were entirely unable to penetrate the blood-brain barrier (BBB) and central nervous system (CNS). |
| T199 | 2599-2733 | Sentence | denotes | In addition, 15 compounds presented a good renal elimination and were not substrates of the renal organic cation transporter 2 (OCT2). |
| T200 | 2734-2989 | Sentence | denotes | Finally, 14 compounds did not present any particular toxicity problems including AMES toxicity, maximum tolerated dose, hERG I inhibitor, hERG II inhibitor, oral rat acute toxicity (LD50), hepatotoxicity, skin sensitisation, and minnow toxicity (Fig. 7B). |
| T201 | 2990-3038 | Sentence | denotes | Table 2 20 potential active compounds from QFPD. |
| T202 | 3039-3104 | Sentence | denotes | Pubchem Molecular Name Structure Pubchem Molecular Name Structure |
| T203 | 3105-3165 | Sentence | denotes | CID6918970 M3 ZINC5356864 CID10019512 S5 3-O-Methylviolanone |
| T204 | 3166-3211 | Sentence | denotes | CID336327 M5 Medicarpin CID9064 W5 Cianidanol |
| T205 | 3212-3258 | Sentence | denotes | CID14057197 O1 – CID182232 W11 (+)-Epicatechin |
| T206 | 3259-3315 | Sentence | denotes | CID42607889 O2 Alysifolinone CID25721350 X1 ZINC13130930 |
| T207 | 3316-3373 | Sentence | denotes | CID3902 S1 letrozole CID14135323 X2 (2S)-dihydrobaicalein |
| T208 | 3374-3423 | Sentence | denotes | CID821279 X4 ZINC338038 CID439246 MXO1 naringenin |
| T209 | 3424-3483 | Sentence | denotes | CID440833 MS1 Leucocyanidol CID676152 SO1 SR-01,000,767,148 |
| T210 | 3484-3546 | Sentence | denotes | CID177149 MX16 (+)-Vestitol CID11438306 SX1 cyclo(L-Tyr-l-Phe) |
| T211 | 3547-3604 | Sentence | denotes | CID114829 MX17 Liquiritigenin CID712316 WO1 (-)-taxifolin |
| T212 | 3605-3667 | Sentence | denotes | CID928837 MX8 ZINC519174 CID373261 XO1 Eriodyctiol (flavanone) |
| T213 | 3668-3696 | Sentence | denotes | M: MXSG, S: SGMH, X: XCH, O: |
| T214 | 3697-3704 | Sentence | denotes | Others. |
LitCovid-PD-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
|---|---|---|---|---|---|
| T2 | 3587-3590 | GlycoEpitope | denotes | WO1 | http://www.glycoepitope.jp/epitopes/AN0690 |